Report: FDA Commissioner Says ‘No Plans’ to Pull Abortion Drugs
Food and Drug Administration (FDA) Commissioner Martin Makary said on Thursday he has “no plans to take action” to restrict the availability of mifepristone, the first drug used in a two-drug medication abortion regimen.
